The difference in morbidity and mortality between adult and pediatric coronavirus disease
2019 infections is dramatic. Understanding pediatric‐specific acute and delayed immune …

Children and adolescents exhibit a broad range of clinical outcomes from SARS-CoV-2
infection, with the majority having minimal to mild symptoms. Additionally, some succumb to …

Coronavirus disease 2019 in children presents with milder clinical manifestations than in
adults. On the other hand, the presence of a wide range of inflammatory manifestations …

Host immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
especially in children, are still under investigation. Children with coronavirus disease 2019 …

The newly identified strain of the Coronaviridae family called severe acute respiratory
syndrome (SARS-CoV-2) recently became the most significant health threat for adults and …

The devastating impact of the COVID-19 pandemic on global health and economic stability
is immeasurable. The situation is dynamic and fast-evolving, with the world facing new …

Children are unique in the context of the COVID-19 pandemic. Overall, SARS-CoV-2 has a
lower medical impact in children as compared to adults. A higher proportion of children than …

There is a striking age-related disparity in the prevalence and severity of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced coronavirus disease 2019 …

A previously immune-naive world population is experiencing natural infection with SARS-
CoV-2. Severe COVID-19 predominantly impacts adults, yet multisystem inflammatory …

Abstract Coronavirus disease 2019 (COVID‐19), can present with a wide spectrum of
severity. Elderly patients with cardiac, pulmonary and metabolic comorbidities are more …